Sun Pharmaceutical Industries

sun-pharma

Sun Pharma, ICGEB to develop botanical drug for dengue

Sun Pharmaceutical Industries today signed a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel botanical drug for treatment of dengue.

Sun Pharma, ICGEB to develop botanical drug for dengue

Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in US

The drug has some presence of ‘unknown impurity’, which was manufactured at the company’s Halol facility in Gujarat Around 3.8 lakh cartons of an osteoporosis drug manufactured by Sun Pharmaceutical Industri

Sun completes sale of two Ranbaxy divisions to Strides Shasun

The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore Sun Pharmaceutical Industries has completed the process of selling two divisions of erstwhile Ranbaxy Laborat

Sun Pharma raises Rs 1,000 crore via NCDs

NCDs will be listed on BSE under two series Sun Pharmaceutical Industries has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. “Sun Pharma Laboratories, a wholly-ow

Sun Pharma receives warning letter for Halol facility

The company expects a re-inspection by US FDA Sun Pharmaceutical Industries has received a warning letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat. Sun Pharma re

Sun Pharma in collaboration with Weizmann Institute of Science, Israel & Health Research Institute of Santiago, Spain for brain therapies

Adopts novel approach towards development of a treatment for glioblastoma, a lethal form of brain cancer Sun Pharmaceutical Industries has entered into a tripartite research and option agreement with Israel-based Weizmann Ins

Sun Pharma receives US FDA approval for Gleevec

These tablets are indicated for the treatment of chronic myeloid leukemia

Sell rating on Sun Pharma; A quarter miss on revenues

Sun Pharma's base business fell due to customer consolidation and competitive pressures

Sun Pharma Q2 net profit down 46% at Rs 1,107 crore

Drug major Sun Pharmaceutical Industries today reported 46.02 per cent dip in its consolidated net profit at Rs 1,106.66 crore for the second quarter...

Sun Pharma Q2 net profit down 46% at Rs 1,107 crore

Sun Pharma acquires InSite Vision

The acquisition was completed by means of a short-form merger under Delaware law Sun Pharmaceutical Industries has acquired InSite Vision Incorporated. The acquisition was completed by means of a short-form merger under Delaw

Sun Pharma seeks shareholders’ nod on Rs 50K cr provision

Sun Pharmaceutical is seeking approval of its shareholders through a postal ballot earmarking of up to Rs 50,000 crore for the purpose of acquisitions or providing loans, among others.

Sun Pharma announces Absorica patent litigation settlement

Ranbaxy Pharmaceuticals along with its partners, Cipher Pharmaceuticals and Galephar Pharmaceutical Research have entered into a settlement agreement with Actavis Group Sun Pharmaceutical Industries announced that Ranbaxy Pha

Sun Pharma commences tender offer for acquisition of InSite Vision

The tender offer will expire on October 27, 2015, at 12:00 midnight New York City time Sun Pharmaceutical Industries has commenced a tender offer through its indirect wholly-owned subsidiary, Thea Acquisition Corporation, for

Retain OW on Sun Pharma, target Rs 1,010: Morgan Stanley

Sun Pharma has announced the acquisition of Insite Vision US for $48 million in equity value (net debt of US$3.5 million in Dec ember 2014).

Retain OW on Sun Pharma, target Rs 1,010: Morgan Stanley

Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy

The agreement involves transfer of Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides for a consideration of Rs 1,650 million Sun Pharmaceutical Industries and Strides Arcolab have entered into a defi

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement

TRENDING NOW

BUDGET 2019

Related Articles

Switch to Hindi Edition
FinancialExpress_1x1_Imp_Desktop